[go: up one dir, main page]

NO20001042D0 - Oftalmiske preparater med forsinket frigivelse inneholdende vannoppløselige medikamenter - Google Patents

Oftalmiske preparater med forsinket frigivelse inneholdende vannoppløselige medikamenter

Info

Publication number
NO20001042D0
NO20001042D0 NO20001042A NO20001042A NO20001042D0 NO 20001042 D0 NO20001042 D0 NO 20001042D0 NO 20001042 A NO20001042 A NO 20001042A NO 20001042 A NO20001042 A NO 20001042A NO 20001042 D0 NO20001042 D0 NO 20001042D0
Authority
NO
Norway
Prior art keywords
ophthalmic
containing water
delayed release
preparations containing
release preparations
Prior art date
Application number
NO20001042A
Other languages
English (en)
Other versions
NO20001042L (no
Inventor
Lyle M Bowman
James F Pfeiffer
Original Assignee
Insite Vision Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25507756&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20001042(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Insite Vision Inc filed Critical Insite Vision Inc
Publication of NO20001042D0 publication Critical patent/NO20001042D0/no
Publication of NO20001042L publication Critical patent/NO20001042L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
NO20001042A 1997-11-04 2000-03-01 Oftalmiske preparater med forsinket frigivelse inneholdende vannoppløselige medikamenter NO20001042L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/963,815 US6159458A (en) 1997-11-04 1997-11-04 Sustained release ophthalmic compositions containing water soluble medicaments
PCT/US1998/023434 WO1999022713A1 (en) 1997-11-04 1998-11-04 Sustained release ophthalmic compositions containing water soluble medicaments

Publications (2)

Publication Number Publication Date
NO20001042D0 true NO20001042D0 (no) 2000-03-01
NO20001042L NO20001042L (no) 2000-05-04

Family

ID=25507756

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001042A NO20001042L (no) 1997-11-04 2000-03-01 Oftalmiske preparater med forsinket frigivelse inneholdende vannoppløselige medikamenter

Country Status (13)

Country Link
US (1) US6159458A (no)
EP (1) EP1028707B1 (no)
JP (1) JP2001521885A (no)
AT (1) ATE213405T1 (no)
AU (1) AU745339B2 (no)
CA (1) CA2302379A1 (no)
DE (1) DE69803940T2 (no)
DK (1) DK1028707T3 (no)
ES (1) ES2172242T3 (no)
NO (1) NO20001042L (no)
NZ (1) NZ503063A (no)
PT (1) PT1028707E (no)
WO (1) WO1999022713A1 (no)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6685958B2 (en) 2001-04-25 2004-02-03 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
US6699492B2 (en) 1999-03-31 2004-03-02 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
US7056893B2 (en) 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US7141607B1 (en) 2000-03-10 2006-11-28 Insite Vision Incorporated Methods and compositions for treating and inhibiting retinal neovascularization
US7708711B2 (en) 2000-04-14 2010-05-04 Glaukos Corporation Ocular implant with therapeutic agents and methods thereof
US7867186B2 (en) 2002-04-08 2011-01-11 Glaukos Corporation Devices and methods for treatment of ocular disorders
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
EP2263621B1 (en) 2001-04-07 2015-05-20 Glaukos Corporation System for treating ocular disorders
US7678065B2 (en) 2001-05-02 2010-03-16 Glaukos Corporation Implant with intraocular pressure sensor for glaucoma treatment
AU2002305400A1 (en) 2001-05-03 2002-11-18 Glaukos Corporation Medical device and methods of use for glaucoma treatment
US7331984B2 (en) 2001-08-28 2008-02-19 Glaukos Corporation Glaucoma stent for treating glaucoma and methods of use
US7163543B2 (en) 2001-11-08 2007-01-16 Glaukos Corporation Combined treatment for cataract and glaucoma treatment
US7951155B2 (en) 2002-03-15 2011-05-31 Glaukos Corporation Combined treatment for cataract and glaucoma treatment
US9301875B2 (en) 2002-04-08 2016-04-05 Glaukos Corporation Ocular disorder treatment implants with multiple opening
US7642258B2 (en) * 2002-04-19 2010-01-05 Allergan, Inc. Combination of brimonidine and timolol for topical ophthalmic use
US7030149B2 (en) 2002-04-19 2006-04-18 Allergan, Inc. Combination of brimonidine timolol for topical ophthalmic use
AU2002325220A1 (en) * 2002-05-24 2003-12-12 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Drop-forming ophthalmic gel preparation comprising diclofenamide and timolol
JP5583310B2 (ja) * 2002-12-20 2014-09-03 チャクシュ・リサーチ・インコーポレーテッド 眼球の症状の予防及び治療のための眼科用製剤
US20060166879A1 (en) * 2002-12-20 2006-07-27 Chakshu Research Inc Treatment of conditions associated with the presence of macromolecular aggregates, particularly ophthalmic disorders
US20060177430A1 (en) * 2002-12-20 2006-08-10 Chakshu Research Inc Treatment of ocular disorders with ophthalmic formulations containing methylsulfonylmethane as a transport enhancer
US20060172972A1 (en) * 2002-12-20 2006-08-03 Chakshu Research Inc Formulation and method for administration of ophthalmologically active agents
DE602005015936D1 (de) * 2004-02-26 2009-09-24 Bausch & Lomb Viskoelastische alginat-zusammensetzung, herstellungsverfahren und verpackung
US20060046970A1 (en) * 2004-08-31 2006-03-02 Insite Vision Incorporated Topical otic compositions and methods of topical treatment of prevention of otic infections
EA200800338A1 (ru) * 2005-07-15 2008-08-29 Чакшу Рисерч Инк. Профилактика и лечение офтальмологических осложнений диабета
BRPI0620080A2 (pt) * 2005-12-19 2011-11-01 Comentis Inc formulações tópicas de mecamilamina para adminstração ocular e usos das mesma
DE102006020604A1 (de) * 2006-05-02 2007-11-08 Bayer Healthcare Ag Flüssige Arzneimittelformulierung
US20070281894A1 (en) * 2006-06-05 2007-12-06 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted erythromycin analogs
US20080021068A1 (en) * 2006-07-24 2008-01-24 Akorn, Inc. Aqueous gel formulation and method for inducing topical anesthesia
US8506515B2 (en) 2006-11-10 2013-08-13 Glaukos Corporation Uveoscleral shunt and methods for implanting same
US8778999B2 (en) 2009-03-05 2014-07-15 Insite Vision Incorporated Non-steroidal anti-inflammatory ophthalmic compositions
US12478503B2 (en) 2009-05-18 2025-11-25 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
EP4289416A3 (en) 2009-05-18 2024-01-03 Dose Medical Corporation Drug eluting ocular implant
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
JP2011093891A (ja) * 2009-09-30 2011-05-12 Rohto Pharmaceutical Co Ltd 眼科用組成物
US9522153B2 (en) 2009-12-22 2016-12-20 Allergan, Inc. Compositions and methods for lowering intraocular pressure
US9668915B2 (en) 2010-11-24 2017-06-06 Dose Medical Corporation Drug eluting ocular implant
US10245178B1 (en) 2011-06-07 2019-04-02 Glaukos Corporation Anterior chamber drug-eluting ocular implant
EP3659495B1 (en) 2011-09-13 2022-12-14 Dose Medical Corporation Intraocular physiological sensor
US9730638B2 (en) 2013-03-13 2017-08-15 Glaukos Corporation Intraocular physiological sensor
JP6655610B2 (ja) 2014-05-29 2020-02-26 グローコス コーポレーション 制御された薬物送達機能を備えるインプラント及びそれを使用する方法
WO2017040853A1 (en) 2015-09-02 2017-03-09 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
US11564833B2 (en) 2015-09-25 2023-01-31 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
CN109937025B (zh) 2016-04-20 2022-07-29 多斯医学公司 生物可吸收眼部药物的递送装置
CN110381960A (zh) 2017-02-02 2019-10-25 麦克马斯特大学 作为抗微生物剂的增强剂的碳酸氢盐
WO2020024060A1 (en) 2018-08-01 2020-02-06 Mcmaster University Methods for inhibiting microbe growth

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
US4271143A (en) * 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
US4911920A (en) * 1986-07-30 1990-03-27 Alcon Laboratories, Inc. Sustained release, comfort formulation for glaucoma therapy
US5209927A (en) * 1985-01-23 1993-05-11 Alcon Laboratories, Inc. Ophthalmic solution
US5192535A (en) * 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5075104A (en) * 1989-03-31 1991-12-24 Alcon Laboratories, Inc. Ophthalmic carboxy vinyl polymer gel for dry eye syndrome
WO1993017664A1 (en) * 1992-03-02 1993-09-16 Alcon Laboratories, Inc. Combinations of cellulosic polymers and carboxy vinyl polymers and their use in pharmaceutical compositions
DE4209722C3 (de) * 1992-03-25 1997-06-19 Medproject Pharma Entwicklungs Tropfbares Gel für die Augenheilkunde
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5521168A (en) * 1994-10-13 1996-05-28 Alcon Laboratories, Inc. Estrogen metabolites for lowering intraocular pressure

Also Published As

Publication number Publication date
NO20001042L (no) 2000-05-04
PT1028707E (pt) 2002-07-31
ATE213405T1 (de) 2002-03-15
AU745339B2 (en) 2002-03-21
EP1028707B1 (en) 2002-02-20
ES2172242T3 (es) 2002-09-16
WO1999022713A1 (en) 1999-05-14
AU1303699A (en) 1999-05-24
DK1028707T3 (da) 2002-06-17
US6159458A (en) 2000-12-12
DE69803940D1 (de) 2002-03-28
EP1028707A1 (en) 2000-08-23
DE69803940T2 (de) 2002-10-02
NZ503063A (en) 2002-04-26
JP2001521885A (ja) 2001-11-13
CA2302379A1 (en) 1999-05-14

Similar Documents

Publication Publication Date Title
NO20001042L (no) Oftalmiske preparater med forsinket frigivelse inneholdende vannoppløselige medikamenter
AU1729397A (en) Process to prepare soluble delivery systems using volatile salts
BR0103033A (pt) Partìculas farmacêuticas de sabor mascarado
DK0839026T3 (da) Micellære polyether-blokcopolymerkompositioner til målretning af biologiske midler
CA2416383A1 (en) Solution-, dispersion- or emulsion-producing film dermatics
DK0703786T3 (da) Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS
FI973452A7 (fi) Nauhoitettu annosmuoto aktiivisen aineen pidennettyyn jakamiseen
AU6675198A (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
MY129406A (en) Taste masked liquid pharmaceutical compositions
ATE245450T1 (de) Haftende mikrokügelchen umfassende zusammensetzung zur arzneimittelgabe
NZ510487A (en) Pharmaceutical composition comprising ciprofloxacin, sodium alginate, xanthan gum and a cross-linker polymer in a tablet or capsule form
DE69934582D1 (de) Delavirdin tablettenformulierung
DE60038536D1 (de) Matrixsystem mit verzögerter freisetzung für hochlösliche wirkstoffe
IL115138A (en) Implantable polymer-containing molded articles for the administration of active substances to plants and processes for the preparation thereof
DK1167354T3 (da) Racemisk huperzin A
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
CA2290482A1 (en) Fructan containing composition for the prevention and treatment of colon cancer
AU5673399A (en) Compositions and methods for treating intracellular infections
MA26777A1 (fr) Inhibiteurs d'aminotransferase dependante d'aminoacide en chaine ramifiee et leur usage dans le traitement de la retinopathie diabetique.
PL324690A1 (en) Improved therapeutic agents
EP0651634A1 (en) CROSSLINKED POLYHYDROXYL MATERIAL FOR ENZYMATICALLY CONTROLLED DRUG RELEASE.
WO2001085188A3 (en) Use of echinacea as a hematinic agent
BG103739A (en) Aqueous pharmaceutical composition containing hard soluble active substance in water
PT1144420E (pt) Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao
GEP20043377B (en) Pharmaceutical Complex

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application